Antibody-mediated rejection in liver transplant recipients: Some questions, some answers
- PMID: 37548557
- DOI: 10.1097/LVT.0000000000000239
Antibody-mediated rejection in liver transplant recipients: Some questions, some answers
Comment on
-
Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study.Liver Transpl. 2023 Dec 1;29(12):1313-1322. doi: 10.1097/LVT.0000000000000200. Epub 2023 Jun 28. Liver Transpl. 2023. PMID: 37367954
References
-
- Loupy A, Lefaucheur C. Antibody-mediated rejection of solid-organ allografts. N Engl J Med. 2018;379:1150–1160.
-
- Demetris AJ, Bellamy C, Hubscher SG, O'Leary J, Randhawa PS, Feng S, et al. 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection. Am J Transplant. 2016;16:2816–2835.
-
- Kim PTW, Demetris AJ, O’Leary JG. Prevention and treatment of liver allograft antibody-mediated rejection and the role of the ‘two-hit hypothesis. Curr Opin Organ Transpl. 2016;21:209–218.
-
- Madill-Thomsen KS, Gauthier PT, Halloran PF. Abstract# 22 Distinguishing an Antibody-Mediated Rejection-Like State in Liver Transplants with High Expression of NK Cell Transcripts and IFNG Induced Transcripts. Am J Transplant. 2023;6:S349; Abstract 22.
-
- Dumortier J, Conti F, Hiriart J-B, Dharancy S, Duvoux C, Besch C, et al. Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study. Liver Transpl. 2023;29:1313–22.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
